Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats
- PMID: 14743973
- DOI: 10.1007/BF03220184
Effect of P-glycoprotein inhibitors erythromycin and cyclosporin A on brain pharmacokinetics of nimodipine in rats
Abstract
Effect of P-glycoprotein (P-gp) inhibitors erythromycin (Ery) and cyclosporin A(CsA) on brain pharmacokinetics of nimodipine (NMD) in rats was studied. NMD concentrations in rat plasma and brain were determined after iv 2 mg/kg NMD alone, co-administration with Ery and CsA, respectively. It was found that concentrations of NMD in plasma of the three groups had a little difference, but brain concentrations of NMD in rats co-administrated with Ery and CsA were significantly higher than those in rats NMD alone. Significances of NMD in rat brain were found at 20, 40, 60 and 90 min after iv NMD. The brain T(1/2) in rat treated with ery(75.0 min) and CsA(79.0 min) were larger than that (44.2 min) in rats NMD alone. The results indicated that P-gp inhibitors Ery and CsA may increase concentration in rat brain by inhibiting elimination of NMD from brain.
Similar articles
-
Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats.Eur J Drug Metab Pharmacokinet. 2005 Jan-Jun;30(1-2):69-73. doi: 10.1007/BF03226410. Eur J Drug Metab Pharmacokinet. 2005. PMID: 16010864
-
P-glycoprotein restricted transport of nimodipine across blood-brain barrier.Acta Pharmacol Sin. 2003 Sep;24(9):903-6. Acta Pharmacol Sin. 2003. PMID: 12956939
-
Cyclosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats.Acta Pharmacol Sin. 2002 Mar;23(3):225-9. Acta Pharmacol Sin. 2002. PMID: 11918846
-
Comparative Pharmacokinetics of Nimodipine in Rat Plasma and Tissues Following Intraocular, Intragastric, and Intravenous Administration.AAPS PharmSciTech. 2020 Aug 13;21(6):234. doi: 10.1208/s12249-020-01772-3. AAPS PharmSciTech. 2020. PMID: 32794077
-
The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.Mol Pharm. 2009 Nov-Dec;6(6):1883-90. doi: 10.1021/mp900170y. Mol Pharm. 2009. PMID: 19722701
Cited by
-
Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice.Eur J Drug Metab Pharmacokinet. 2014 Mar;39(1):17-24. doi: 10.1007/s13318-013-0135-z. Epub 2013 May 15. Eur J Drug Metab Pharmacokinet. 2014. PMID: 23673491
-
Different effect of erythromycin on absorption kinetics of nimodipine in male and female rats.Eur J Drug Metab Pharmacokinet. 2005 Jan-Jun;30(1-2):69-73. doi: 10.1007/BF03226410. Eur J Drug Metab Pharmacokinet. 2005. PMID: 16010864
-
Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort.Eur J Clin Pharmacol. 2009 Jun;65(6):579-84. doi: 10.1007/s00228-009-0619-6. Epub 2009 Feb 11. Eur J Clin Pharmacol. 2009. PMID: 19205682
-
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.J Nanobiotechnology. 2022 Sep 24;20(1):423. doi: 10.1186/s12951-022-01626-z. J Nanobiotechnology. 2022. PMID: 36153528 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous